Speakers

Mohammad Ali Amini

President & CEO

QurCan Therapeutics Inc., Canada

Florie Borel

Senior Director - Head of Delivery & Preclinical Development

Arbor Biotechnologies, USA

James Burke

Chief Medical Officer

CG Oncology, USA

Victor Cervera-Carrascón

Vice President of Business Development

TILT Biotherapeutics, Finland

Tony De Fougerolles

CEO

Evox Therapeutics Limited

Zhenghong Gao

Director, Non-Viral Delivery

Ask Bio, USA

Gunnel Hallden

Director, Oncolytic Virotherapy

AstraZeneca, UK

Don Haut

CEO & Director

Carmine Therapeutics, USA

Per Sonne Holm

University Professor, Department of Oral and Maxillofacial Surgery

Medical University Innsbruck, Austria

Noriyuki Kasahara

Professor

University of California San Francisco, USA

Howard Kaufman

Lecturer

Harvard Medical School, USA

Johanna Kaufmann

Executive Vice President for Oncology

Codagenix Inc., USA

Lottie Leinfellner

Digital Events Conference Producer

Informa Connect, UK

Angelica Loskog

Professor of Immunotherapy & Chief Executive Officer/Chief Scientific Officer

Uppsala University & Lokon Pharma AB, Sweden

Ming Luo

Professor

Georgia State University, USA

Robert Mabry

Chief Scientific Officer

Orna Therapeutics, USA

Alan Melcher

Team Leader, Centre for Translational Immunotherapy

The Institute of Cancer Research, UK

Abhisek Mitra

Senior Scientist Team Lead

AstraZeneca, USA

Shashi Murthy

CTO & Co-Founder

Nanite Inc., USA

Samuel Rabkin

Thomas A Pappas Professor in Neuroscience

Harvard Medical School, USA

Devyn M. Smith

Chief Executive Officer

Arbor Biotechnologies, USA

Steve Thorne

CSO

KaliVir Immnuotherapeutics, USA

Akshata Udyavar

Sr. Director Immunology and Translational Sciences

Actym Therapeutics, Inc., USA

Richard Vile

Consultant, Department of Molecular Medicine

Mayo Clinic, USA

Rui Zhang

Associate Director, LNP Formulation

Tessera Therapeutics, USA